Table 1 Patients’ characteristics.

From: Good prediction of treatment responses to neoadjuvant chemoradiotherapy for esophageal cancer based on preoperative inflammatory status and tumor glucose metabolism

 

Total

N = 127

pCR

N = 57

Non-pCR

N = 70

p Value

Sex

F:5/M:122

F:3/M:54

F:2/M:68

0.656

Age (years)

Range

35–75

35–75

35–71

0.983

Mean ± SD

54.77 ± 8.22

54.75 ± 9.10

54.85 ± 7.45

 

Site

Cervical

1

0

1

0.433

Thoracic

U

15

8

7

M

24

13

11

L

80

34

46

2 sites

7

2

5

cT

1

1

0

1

0.152

2

3

3

0

3

120

52

68

4

3

2

1

cN

0

6

4

2

0.765

1

70

31

39

2

46

20

26

3

5

2

3

Primary tumor

Range

2–20

2–19

2–20

0.445

Length (cm)

Mean ± SD

6.85 ± 3.13

6.61 ± 2.68

7.01 ± 3.45

 

Time to surgery

Range

15–65

18–63

15–65

0.766

(day)

Mean ± SD

34.71 ± 7.78

33.80 ± 7.72

33.28 ± 7.86

 

Histology

Others

59

28

31

0.930

PD SCC

68

29

39

 

Dissected LN (N)

Range

5–93

7–9

5–74

0.878

Mean ± SD

31.95 ± 15.24

32.18 ± 17.77

31.83 ± 12.89

 
  1. pCR pathological complete response, N number, F female, M male, SD standard deviation, U upper thoracic, M middle thoracic, L lower thoracic, cT clinical T classification, cN clinical N classification, PD SCC poor differentiated squamous cell carcinoma, LN lymph nodes.
Back to article page